Executive Change: Corrixr Therapeutics Appoints Hilary M. Malone, Ph.D. as Chief Executive Office
Newark, DE – Corrixr Therapeutics has announced the appointment of Hilary Malone as Chief Executive Office. About Corrixr Therapeutics: Corrixr Therapeutics is an oncology-focused biotherapeutics company developing targeted genetic medicines designed to disable the NRF2…